[Experimental and clinical research on the antitubercular activity of the N-(4-morpholinomethyl)-amide of pyrazinecarboxylic acid].
D000577:Amides; D000995:Antitubercular Agents; D006801:Humans; D011718:Pyrazinamide / Q000031:analogs & derivatives; D014376:Tuberculosis / Q000628:therapy*
D000577:Amides; D000995:Antitubercular Agents; D011718:Pyrazinamide; C005296:pyrazinoic acid
PYRAZINAMIDE/related compounds; TUBERCULOSIS/therapy